These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39243022)

  • 41. Functional Analyses of Rare Germline Missense
    Hovland HN; Mchaina EK; Høberg-Vetti H; Ariansen SL; Sjursen W; Van Ghelue M; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833189
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Lourenço RA; Lança M; Monteiro Gil O; Cardoso J; Lourenço T; Pereira-Leal JB; Rodrigues AS; Rueff J; Nunes Silva S
    Mol Med Rep; 2023 Jul; 28(1):. PubMed ID: 37232349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants.
    Cline MS; Babbi G; Bonache S; Cao Y; Casadio R; de la Cruz X; Díez O; Gutiérrez-Enríquez S; Katsonis P; Lai C; Lichtarge O; Martelli PL; Mishne G; Moles-Fernández A; Montalban G; Mooney SD; O'Conner R; Ootes L; Özkan S; Padilla N; Pagel KA; Pejaver V; Radivojac P; Riera C; Savojardo C; Shen Y; Sun Y; Topper S; Parsons MT; Spurdle AB; Goldgar DE;
    Hum Mutat; 2019 Sep; 40(9):1546-1556. PubMed ID: 31294896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Premalignant Cell-Based Model for Functionalization and Classification of
    Chao JT; Hollman R; Meyers WM; Meili F; Matreyek KA; Dean P; Fowler DM; Haas K; Roskelley CD; Loewen CJR
    Cancer Res; 2020 Jul; 80(13):2775-2789. PubMed ID: 32366478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
    Billaud A; Chevalier LM; Augereau P; Frenel JS; Passot C; Campone M; Morel A
    Genome Med; 2021 Nov; 13(1):174. PubMed ID: 34749799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BRCA1/2 missense mutations and the value of in-silico analyses.
    Sadowski CE; Kohlstedt D; Meisel C; Keller K; Becker K; Mackenroth L; Rump A; Schröck E; Wimberger P; Kast K
    Eur J Med Genet; 2017 Nov; 60(11):572-577. PubMed ID: 28807866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
    Chen B; Zhang G; Li X; Ren C; Wang Y; Li K; Mok H; Cao L; Wen L; Jia M; Li C; Guo L; Wei G; Lin J; Li Y; Zhang Y; Han-Zhang H; Liu J; Lizaso A; Liao N
    Aging (Albany NY); 2020 Feb; 12(4):3140-3155. PubMed ID: 32091409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas.
    Weile J; Roth FP
    Hum Genet; 2018 Sep; 137(9):665-678. PubMed ID: 30073413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolutionary pathways in BRCA1-associated breast tumors.
    Martins FC; De S; Almendro V; Gönen M; Park SY; Blum JL; Herlihy W; Ethington G; Schnitt SJ; Tung N; Garber JE; Fetten K; Michor F; Polyak K
    Cancer Discov; 2012 Jun; 2(6):503-11. PubMed ID: 22628410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in classification of genetic variants in BRCA1 and BRCA2.
    Kast K; Wimberger P; Arnold N
    Arch Gynecol Obstet; 2018 Feb; 297(2):279-280. PubMed ID: 29302806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.
    Abkevich V; Zharkikh A; Deffenbaugh AM; Frank D; Chen Y; Shattuck D; Skolnick MH; Gutin A; Tavtigian SV
    J Med Genet; 2004 Jul; 41(7):492-507. PubMed ID: 15235020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative model to predict pathogenicity of missense variants in the TP53 gene.
    Fortuno C; Cipponi A; Ballinger ML; Tavtigian SV; Olivier M; Ruparel V; Haupt Y; Haupt S; Study ISK; Tucker K; Spurdle AB; Thomas DM; James PA
    Hum Mutat; 2019 Jun; 40(6):788-800. PubMed ID: 30840781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
    Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
    Lindor NM; Goldgar DE; Tavtigian SV; Plon SE; Couch FJ
    Oncologist; 2013; 18(5):518-24. PubMed ID: 23615697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study.
    Bozsik A; Papp J; Grolmusz VK; Patócs A; Oláh E; Butz H
    Cancer Res Treat; 2022 Oct; 54(4):970-984. PubMed ID: 35167739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimum information and guidelines for reporting a Multiplexed Assay of Variant Effect.
    Claussnitzer M; Parikh VN; Wagner AH; Arbesfeld JA; Bult CJ; Firth HV; Muffley LA; Nguyen Ba AN; Riehle K; Roth FP; Tabet D; Bolognesi B; Glazer AM; Rubin AF
    ArXiv; 2023 Jun; ():. PubMed ID: 37426450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predicting reclassification of variants of unknown significance.
    Wright M; Menon V; Taylor L; Shashidharan M; Westercamp T; Ternent CA
    Am J Surg; 2018 Dec; 216(6):1148-1154. PubMed ID: 30217367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation.
    Gilbert MA; Keefer-Jacques E; Jadhav T; Antfolk D; Ming Q; Valente N; Shaw GT; Sottolano CJ; Matwijec G; Luca VC; Loomes KM; Rajagopalan R; Hayeck TJ; Spinner NB
    Am J Hum Genet; 2024 Aug; 111(8):1656-1672. PubMed ID: 39043182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting the combined effect of multiple genetic variants.
    Liu M; Watson LT; Zhang L
    Hum Genomics; 2015 Jul; 9(1):18. PubMed ID: 26223264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.